Moreover, it serves as an invaluable resource for clinicians, providing evidence-based research to support effective clinical decision-making, accurate diagnosis, and efficient management of viral hepatitis in the patient population.
Table of Contents
1. Unmasking the alphabets: Comprehensive introduction to hepatitis A to E virus infections.2. The liver island: Understanding the implications in the world of hepatitis viruses.
3. Hepatitis A virus: Exploring the role of genetics and immune players.
4. Unleashing the warriors: T-cell subsets and the pathogenesis of hepatitis B virus infection.
5. Exploring the relevance of HBx in hepatitis B virus-associated pathogenesis.
6. miRNA: The stealth regulators of hepatitis B virus pathogenesis.
7. Newer insights on the pathogenesis of hepatitis C virus disease.
8. Unraveling the controversial role of vitamin D in the pathogenesis of viral hepatitis.
9. The delta agent enigma: Beyond co-infection and superinfection with hepatitis B virus.
10. Hepatitis E virus Exploring newer pathways in disease pathogenesis.
11. Human pegivirus: Fighting the human immunodeficiency virus for mere survival or fitness?
12. Microbial allies and foes: Understanding the impact of microbiota in viral hepatitis.
13. Extracellular vesicles and viral hepatitis.
14. Hepatitis and HIV: Converging for fighting humans for a common cause?
Authors
Esaki M. Shankar Central University of Tamil Nadu, India.Dr. Esaki M Shankar, a distinguished professor, brings two decades of expertise in the field of virology, specializing in chronic viral infections. With a strong focus on Hepatitis B and Hepatitis C, Dr. Shankar has dedicated 15 years to researching and understanding these viral strains and establishing a profound understanding of viral hepatitis. Renowned as a skilled medical educator, Dr. Shankar possesses over 15 years of pedagogical experience in viral pathogenesis, shaping the minds of future medical professionals. Driven by a passion for discovery, Dr. Shankar has contributed significantly to the scientific community, with a notable record of publishing over 150 peer-reviewed articles in esteemed indexed journals.
Vijayakumar Velu Emory University School of Medicine, USA.Dr. Vijayakumar Velu is an esteemed researcher renowned for his extensive expertise in chronic viral infections. His current focus revolves around unraveling the intricate dynamics of T cell, B cell, and NK cell subsets in both lymphoid and non-lymphoid tissues. Dr. Velu's work aims to uncover the complex relationship between antiviral immunity and viral reservoirs, seeking effective methods for their control. Notably, his research delves into the characterization of Tissue Resident T cells (TRMs), T follicular Helper cells, and NK cells in macaques co-infected with Mtb and Mtb/SIV. With a comprehensive background in the field, Dr. Velu has accumulated over 100 peer-reviewed publications, solidifying his reputation as a leading expert. Additionally, his outstanding contributions have earned him multiple NIH grants, further amplifying his impact in the realm of viral hepatitis.
Vignesh Ramachandran Universiti Kuala Lumpur, India.Dr. Ramachandran Vignesh is a highly experienced professional with over 15 years of specialization in diagnostic and clinical microbiology. His profound knowledge encompasses various facets of the field, including a strong focus on immune reconstitution disease. Dr. Vignesh's expertise extends to the realms of clinical microbiology and parasitology, where he has made significant contributions. With an impressive portfolio, Dr. Vignesh has earned authorship in over 70 peer-reviewed publications, further establishing his credibility as a respected figure in the scientific community.
